Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-13 @ 11:22 AM
Study NCT ID:
NCT04669067
Status:
UNKNOWN
Last Update Posted:
2023-02-17
First Post:
2020-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TL-895 and KRT-232 Study in Acute Myeloid Leukemia
Sponsor:
Telios Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TL-895-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |